Exchange & Returns Information
Review Details
(32)
| Drug Type | Original |
|---|---|
| Active Ingredient | TIRZEPATIDE |
| Strength | 5MG |
| Manufacturer | ELI LILLY AND COMPANY |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 1 PEN | $ 265.00 | $ 265.00 |
$ 222.60
Apply MOUN26 (-16%)
You save $ 42.40
|
||
| 2 BOXES - 2 PENS | $ 232.50 |
12% $ 530.00
$ 465.00
|
$ 390.60
Apply MOUN26 (-16%)
You save $ 74.40
|
||
| ★ Best Value 3 BOXES - 3 PENS | $ 225.00 |
15% $ 795.00
$ 675.00
|
$ 567.00
Apply MOUN26 (-16%)
You save $ 108.00
|
Reference information will be available soon.
Mounjaro 5mg is the first therapeutic dose of tirzepatide after the 2.5mg initiation period, representing the beginning of active glycemic management. As a once-weekly subcutaneous GLP-1/GIP dual receptor agonist, tirzepatide is approved for the treatment of type 2 diabetes in adults. Its innovative mechanism targets two complementary incretin pathways—GLP‑1 for appetite suppression and insulin secretion, and GIP for enhanced insulinotropic effects and fat metabolism. This dual action enables superior HbA1c reduction and metabolic rebalancing. Though not formally approved for weight loss, consistent reductions in body weight have been demonstrated, and tirzepatide plays a vital role in broader metabolic disease risk modulation. Early studies also indicate promise in slowing prediabetes progression, improving outcomes in obesity-linked obstructive sleep apnea, and possibly reducing the long-term risk of metabolic cancers. Mounjaro 5mg marks the start of personalized escalation, with further titration options based on patient response.
- DIABETES (GLP-1 Receptor Agonists) > Used to improve glycemic control in adults with type 2 diabetes. The 5mg dose is the first active therapeutic dose following 2.5mg titration. It demonstrates powerful HbA1c reduction through its dual incretin receptor action, with additional benefits such as lower postprandial glucose and minimal hypoglycemia risk when used appropriately. - DIET (Metabolic Weight Control) > Tirzepatide shows consistent weight reduction across all dose ranges as a secondary effect. Its action on gastric emptying, appetite suppression, and fat oxidation contributes to clinically meaningful weight loss, particularly in overweight and obese diabetic patients. However, Mounjaro is not a dedicated anti-obesity drug. - LIFESTYLE-RELATED DISEASES (Obstructive Sleep Apnea – off-label) > While not indicated for sleep apnea, studies involving obese patients show that tirzepatide-induced weight loss may improve OSA severity. This effect is linked to the Zepbound version, but clinical overlap exists. Use in OSA remains off-label and investigational. - AntiCancer Drugs (Others – metabolic-linked cancer modulation) > Early preclinical and observational studies suggest that tirzepatide may reduce the risk of developing obesity-associated cancers, such as breast cancer, through improved metabolic homeostasis. Though not an approved indication, this research highlights its long-term preventative potential.
Tirzepatide acts as a dual incretin mimetic, activating both GLP‑1 and GIP receptors. This novel mechanism enhances insulin secretion in a glucose-dependent manner, inhibits glucagon release, and delays gastric emptying. GIP activation contributes to adipocyte modulation and metabolic flexibility. The synergy between these pathways enables more effective glycemic and weight control compared to single-pathway agents like GLP‑1 monotherapy. Tirzepatide has demonstrated superior HbA1c reduction, improved insulin sensitivity, and a favorable impact on metabolic biomarkers such as triglycerides and C-reactive protein.
→ Weekly Subcutaneous Injection (Type 2 Diabetes Indication): - Week 1–4: 2.5 mg SC once weekly *(Initiation phase only)* - Week 5+: Increase to 5 mg SC once weekly *(This product)* - Further escalation: - 7.5 mg → 10 mg → 12.5 mg → up to 15 mg weekly (at 4-week intervals if tolerated) → Maintenance Dose: 5–15 mg SC per week based on efficacy and tolerability → Maximum Dose: 15 mg per week → Administration Notes: - Inject into abdomen, upper arm, or thigh - Same day each week, with or without food - If a dose is missed, inject within 96 hours; skip if longer → Drug Interactions / Adjustments: - May be used alone or with metformin, SGLT2 inhibitors, sulfonylureas, or basal insulin - When starting tirzepatide with insulin or sulfonylureas, dose reduction is recommended to minimize hypoglycemia risk → Special Considerations: - Do not use in type 1 diabetes or diabetic ketoacidosis - Contraindicated in patients with a history of medullary thyroid carcinoma or MEN2 - Monitor renal function, pancreatitis risk, and diabetic retinopathy in high-risk individuals → Off-Label Observations: - Shown to reduce the progression rate from prediabetes to diabetes by up to 94% in some studies - Associated with weight loss in obese patients with comorbid OSA - Investigated for metabolic modulation in obesity-linked cancers and neurodegenerative disease models
Store unused pens in the refrigerator (2–8°C). Do not freeze. Once in use, pens may be stored at room temperature (below 30°C) for up to 21 days. Protect from light and moisture. Keep out of reach of children.
Common side effects include nausea, vomiting, constipation, diarrhea, and decreased appetite. These are typically transient and dose-dependent. Other possible effects include fatigue, dizziness, indigestion, and injection site reactions. Serious adverse events may involve pancreatitis, gallbladder disease, acute kidney injury, or hypersensitivity reactions. Low hypoglycemia risk unless used with insulin or sulfonylureas. Contact a healthcare provider for persistent or severe reactions.
I'm not getting those afternoon slumps like I used to. A very welcome benefit.
Had a follow-up, and my numbers are already improving. Mounjaro is working well for me.
It's great to have a source that provides such reliable and professional service to Canada.
I was hopeful when I started Mounjaro, but now, after a month on the 5mg dose, I'm a true believer. The changes in my appetite and energy levels are significant and consistent. I feel more in control of my health than ever. This positive momentum is supported by the flawless service from this site. My reorder was simple, and the delivery was, once again, perfect. Their professionalism gives me the confidence to focus on my health goals.
The transition to 5mg was smooth, with no noticeable side effects for me.
No combo deals available at the moment.
